Indonesia To Resume Use Of AstraZeneca’s COVID-19 Vaccine

Jakarta: (HRNW) Indonesia’s Food and Drug agency (BPOM) said on Friday it has approved the usage of AstraZeneca’s COVID-19 vaccine after reviewing reports that it had caused blood clots among some recipients in Europe.

The agency said that even though vaccination could lead to “adverse events” following immunisation, “the risk of death from COVID-19 is much higher.”

“The benefits of giving the AstraZeneca COVID-19 vaccine outweigh the risks,” the agency said in a statement.

Distribution of the AstraZeneca vaccine would start by next Monday, health ministry official Siti Nadia Tarmizi said.

“The earlier we distribute the vaccine, the earlier we can get out of this pandemic,” she told a news conference.

Be the first to comment on "Indonesia To Resume Use Of AstraZeneca’s COVID-19 Vaccine"

Leave a comment

Your email address will not be published.


*